Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03251170Phase 4Completed
Phase 4, randomised trial of ketamine in septic shock (2 arms), sponsored by Cairo University. Primary endpoint: Mean Arterial Pressure at 30 minutes. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03251170.